Healios KK (HLOSF)
1.50
0.00 (0.00%)
USD |
OTCM |
Nov 14, 16:00
Healios Shareholders Equity (Quarterly): 20.16M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 20.16M |
| March 31, 2024 | 24.45M |
| December 31, 2023 | 27.34M |
| September 30, 2023 | 37.48M |
| June 30, 2023 | 22.40M |
| March 31, 2023 | 28.92M |
| December 31, 2022 | 33.42M |
| September 30, 2022 | 31.77M |
| June 30, 2022 | 32.66M |
| March 31, 2022 | 55.56M |
| December 31, 2021 | 75.07M |
| September 30, 2021 | 94.22M |
| June 30, 2021 | 51.51M |
| March 31, 2021 | 64.50M |
| December 31, 2020 | 76.06M |
| September 30, 2020 | 89.78M |
| June 30, 2020 | 108.99M |
| March 31, 2020 | 123.56M |
| December 31, 2019 | 113.27M |
| Date | Value |
|---|---|
| September 30, 2019 | 95.58M |
| June 30, 2019 | 84.95M |
| March 31, 2019 | 90.04M |
| December 31, 2018 | 130.21M |
| September 30, 2018 | 110.70M |
| June 30, 2018 | 118.94M |
| March 31, 2018 | 147.42M |
| December 31, 2017 | 143.37M |
| September 30, 2017 | 117.95M |
| June 30, 2017 | 117.63M |
| March 31, 2017 | 67.27M |
| December 31, 2016 | 51.54M |
| September 30, 2016 | 62.23M |
| June 30, 2016 | 65.48M |
| March 31, 2016 | 64.46M |
| December 31, 2015 | 77.83M |
| September 30, 2015 | 81.30M |
| June 30, 2015 | 72.83M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
20.16M
Minimum
Jun 2024
123.56M
Maximum
Mar 2020
58.48M
Average
51.51M
Median
Jun 2021
Shareholders Equity (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | 48.46B |
| Nxera Pharma Co Ltd | 428.64M |
| PeptiDream Inc | 365.20M |
| AnGes Inc | 158.32M |
| SanBio Co Ltd | 10.30M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 110.68M |
| Total Liabilities (Quarterly) | 90.39M |
| Debt to Equity Ratio | 1.863 |
| Current Ratio | 1.386 |
| Net Debt Paydown Yield | 2.62% |